Healthcare & Life Sciences
Hummingbird Bioscience
China
series-c-plus
series-c-plus
Stage
3
Investors
About
Hummingbird Bioscience is a clinical-stage biotechnology company developing precision therapies targeting difficult-to-drug proteins to improve patient outcomes.
Explore Hummingbird Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.